Gender-Specific Effects of Genetic Variants within Th1 and Th17 Cell-Mediated Immune Response Genes on the Risk of Developing Rheumatoid Arthritis

• Rafael Cáliz ,

  Contributed equally to this work with: Rafael Cáliz, Luz María Canet

  Affiliation Rheumatology Department, Virgen de las Nieves University Hospital, Granada, Spain

  ⨯
• Luz María Canet ,

  Contributed equally to this work with: Rafael Cáliz, Luz María Canet

  Affiliation Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain

  ⨯
• Carmen Belén Lupiañez,

  Affiliation Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain

  ⨯
• Helena Canhão,

  Affiliations Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal, Rheumatology Department, Santa Maria Hospital–CHLN, Lisbon, Portugal

  ⨯
• Alejandro Escudero,

  Affiliation Rheumatology Department, Reina Sofía Hospital, Córdoba, Spain

  ⨯
• Ileana Filipescu,

  Affiliation Rheumatology Department, Reina Sofía Hospital, Córdoba, Spain

  ⨯
• Juana Segura-Catena,

  Affiliation Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain

  ⨯
• María José Soto-Pino,

  Affiliation Rheumatology Department, Virgen de las Nieves University Hospital, Granada, Spain

  ⨯
• Manuela Expósito-Ruiz,

  Affiliation FIBAO Fundation, Virgen de las Nieves University Hospital, Granada, Spain

  ⨯
• Miguel Ángel Ferrer,

  Affiliation Rheumatology Department, Virgen de las Nieves University Hospital, Granada, Spain

  ⨯
• Antonio García,

  Affiliation Rheumatology Department, Virgen de las Nieves University Hospital, Granada, Spain

  ⨯
• Lurdes Romani,

  Affiliation Rheumatology Department, Virgen de las Nieves University Hospital, Granada, Spain

  ⨯
• Alfonso González-Utrilla,

  Affiliation Rheumatology Department, Virgen de las Nieves University Hospital, Granada, Spain

  ⨯
• Teresa Vallejo,

  Affiliation Rheumatology Department, Virgen de las Nieves University Hospital, Granada, Spain

  ⨯
• Eva Pérez-Pampin,

  Affiliation Rheumtology Unit, Instituto de Investigacion Sanitaria-Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain

  ⨯
• Kari Hemminki,

  Affiliations Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany, Center for Primary Health Care Research, Clinical Research Center, Malmö, Sweden

  ⨯
• Asta Försti,

  Affiliations Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany, Center for Primary Health Care Research, Clinical Research Center, Malmö, Sweden

  ⨯
• Eduardo Collantes,

  Affiliation Rheumatology Department, Reina Sofía Hospital, Córdoba, Spain

  ⨯
• João Eurico Fonseca,

  Affiliations Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal, Rheumatology Department, Santa Maria Hospital–CHLN, Lisbon, Portugal

  ⨯
•  [ ... ],
• Juan Sainz

  * E-mail: juan.sainz@genyo.es

  Affiliations Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain, Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany

  ⨯
• [ view all ]
• [ view less ]